Fasting Clinical Trial
Official title:
The Effects of Prolonged Fasting on the Microbiome and HDL Particles of Human Subjects
Participants will undergo one day of habitual eating followed by 36 hours of water only fasting and final day of habitual eating of the exact same diet consumed on the first eating day. Blood draws will be performed on Day 1 in a 10-12 hr fasted state and 2 hour postprandial state and again on Day 3 in a 36hr fasted state and a 2 hour post prandial state. Microbiome samples and blood glucose data will be collected throughout the course of the study.
Screening and Consent:
Prospective subjects who pass the initial phone screening interview (i.e. meet
inclusion/exclusion criteria) will be admitted into the study and scheduled for a consent
visit. At the consent visit, subjects who decide to participate will be given a series of
questionnaires including a health history questionnaire, physical activity questionnaire, and
will be asked to complete a 3-day diet record, to be completed before the baseline visit at
the beginning of the study. Women who consent to participate will be scheduled to complete
the study within the follicular phase and menses of the menstrual cycle to avoid confounding
alterations in lipoproteins.
Study Visit1 (Baseline fasted):
On Day 1 of the study protocolstudy participants will report to the Ragle Human Nutrition
Research Center located on the UC Davis campus (1283 Academic Surge, University of
California, Davis, in Davis CA 95616) for a 12-hour overnight fasting blood draw and
anthropometric measurements at approximately 8AM. Any participants that are found to have
fasting glucose above or below 70-100mg/dL will be removed from the study. Study participants
will be given a Precision Xtra Blood Ketone Testing Kit to collect blood ketone data during
the fasting period of the study protocol, a set of stool collection kits to collect stool
samples throughout the rest of the study protocoland fitted with a GoBe activity monitor to
track physical activity throughout the rest of the study protocol. Proper use, care, and
storage of the Precision Xtra systems, stool collection kits, and GoBe monitors will be
explained in detail to study participants during the baseline visit. Study participants will
be given a 24-hr food diary to record their food and beverage intake throughout the rest of
the day or may be asked to track their diet using GB 360.
Study Visit 2 (Baseline postprandial):
After the baseline visit on Day 1 of the study protocol, study participants will go about
their normal routines and eat their habitual diet ad libitum while recording their dietary
intake throughout the day. This food record will be used in order for the study participants
to mimic their food intake on Day 1 during the eating period on Day 3 of the study protocol.
Study participants will eat their last meal of the day at approximately 6PM. Post-prandial
blood samples will be collected at 2 hours after the ingestion of this last meal and
immediately processed to yield patient plasma and isolated PBMCs to be stored for future
analysis. These post-prandial samples will constitute the baseline "Fed" state of each
participant. Study participants will also perform their first bloodprick for ketone
measurement using the Precision Xtra Monitor under instruction and supervision by study
personnel.
Fasting:
After ingestion of their final meal, participants will undergo a full 36 hours of fasting
comprising Day 2 and the beginning of Day 3 of the trial without otherwise modifying their
typical routine, including drinking coffee or tea (but with no creamers or sweeteners of any
kind), if this is part of their normal routine. The time of the ingestion of the standardized
meal will be used as the start point (0hr) for the continuous 36 hours of fasting. 36 hrs of
fasting has been shown to be well tolerated in human subjects and was chosen for this trial
as it represents the approximate amount of time that fasting would be experienced during a
single cycle of an alternate day fasting regimen. Therefore, results from this study could be
generalized to plan for future studies of alternate day fasting. Subjects will be encouraged
to report any feelings of dizziness, headaches, nausea, or severe hunger that they may
experience and, based on the severity of their conditions, will be advised whether or not to
continue with the trial. Subjects will be asked to take small blood pricks starting
immediately after waking up on Day 2 and then every 3 conscious hours thereafter using
thePrecision Xtra Blood Ketone Testing Kits in order to test blood ketone levels during the
fasting period. Ketone levels obtained from the blood pricks will be recorded automatically
by the Precision Xtra monitor.
Study Visit 3 (Post 36h fasted):
At 36 hours of fasting, roughly 8AM on Day 3, subjects will return to the Ragle Center,
perform a final blood prick for ketone monitoring by the Precision Xtra and their blood
samples will be collected and again immediately processed and stored for future analysis
constituting the "Fasted" state for each participant.
Study Visit 4 (Post 36h postprandial):
After the blooddraw at Study Visit 3, study participants will be allowed free access to food
throughout the rest of the day and asked to eat an identical diet to the dietary intake the
participants recorded on Day 1 in their 24 hour food diary. Subjects will eat their last meal
at approximately 6PM. Post-prandial blood samples will be collected at 2 hours after the
ingestion of this last meal and immediately processed to yield patient plasma and isolated
PBMCs to be stored for future analysis. These post-prandial samples will constitute the
"Refed" state of each participant. After this final blood draw, the Precision Xtra system
will be collected, the GoBe removed, and the activity and ketone data collected throughout
the course of the study will be transferred to a secure computer for analysis. Fasting
compliance will be determined as 1) increasing or steady ketone levels throughout the 36hr
fasting period and 2) the absence of significant drops in blood ketone levels, which would
indicate food intake and noncompliance.
StoolCollection (Days 1-3):
Study participants will use the provided stool collection kits to collect stool samples from
each bowel movement throughout the entire course of the study. Stool samples will be obtained
from study participants at the Ragle Center as soon as possible after initial collection by
study participants, frozen, and stored at -80C.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT03754920 -
Prolonged Fasting With Meditation and Mild Physical Exercise
|
N/A | |
Completed |
NCT05272332 -
Gastric Ultrasound Prior to Extubation
|
||
Completed |
NCT04247464 -
Short-term Fasting as an Enhancer of Chemotherapy: Pilot Clinical Study on Colorectal Carcinoma Patients
|
N/A | |
Completed |
NCT01067001 -
Minocycline HCl Extended Release Tablets 135 mg Oral Bioequivalence Study
|
N/A | |
Completed |
NCT00757094 -
Safety and Feasibility of Fasting While Receiving Chemotherapy
|
N/A | |
Completed |
NCT01506713 -
Bioequivalence Study of Clopidogrel Tablets 75 mg of Dr. Reddy's Under Fasting Conditions
|
Phase 1 | |
Completed |
NCT04514380 -
Effect of Drinking Carbohydrate-containing Fluids on Gastric Residual Volume in Elderly Patients
|
||
Completed |
NCT05756868 -
The Effect of Time-Restricted Feeding on Anthropometry, Biochemical Parameters, Diet Quality and Eating Behavior
|
N/A | |
Completed |
NCT05134207 -
The Effect of Oral Carbohydrate Solution on Anxiety and Comfort in Patients Undergoing Hip Arthroplasty
|
N/A | |
Completed |
NCT05031598 -
Long-term Fasting: Multi-system Adaptations in Humans
|
N/A | |
Recruiting |
NCT04501393 -
Recommended Clear Fluid Intake Volume at 2 Hours Prior to Esophagogastroduodenoscopy for Adult Patients
|
N/A | |
Enrolling by invitation |
NCT04027478 -
Can Fasting Decrease the Side Effects of Chemotherapy?
|
N/A | |
Completed |
NCT05219136 -
Improve the Comfort, Safety and Quality of Upper Endoscopy by a Modified Fasting Protocol
|
N/A | |
Recruiting |
NCT04625608 -
Effect of Premedicant Oral Paracetamol on Gastric Volume and pH
|
Phase 4 | |
Not yet recruiting |
NCT02562638 -
Pre-Procedural Fasting in Cardiac Intervention
|
N/A | |
Completed |
NCT01954836 -
Short-Term Fasting During Chemotherapy in Patients With Gynecological Cancer- a Randomized Controlled Cross-over Trial
|
N/A | |
Completed |
NCT01949987 -
Does Oral Intake Decreases Postoperative Pain Score in Children
|
N/A | |
Completed |
NCT01721187 -
Satiety Effects on the Neural Valuation of Food
|
N/A | |
Completed |
NCT01713647 -
Bioequivalence Study of Amlodipine / Losartan/ Hydrochlorothiazide of PHARMALINE, Lebanon Under Fastion Conditions
|
Phase 1 | |
Completed |
NCT01746719 -
Bioequivalence Study of Etodolac Capsules USP 300 mg Under Fasting Condition
|
Phase 1 |